Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Stroke Cerebrovasc Dis ; 27(10): 2725-2730, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30076114

ABSTRACT

OBJECTIVE: To compare whites and African-Americans in terms of dementia risk following index stroke. METHODS: The data consisted of billing and International Classification of Diseases, Ninth Revision diagnosis codes from the South Carolina Revenue and Fiscal Affairs office on all hospital discharges within the state between 2000 and 2012. The sample consisted of 68,758 individuals with a diagnosis of ischemic stroke prior to 2010 (49,262 white [71.65%] and 19,496 African-Americans [28.35%]). We identified individuals in the dataset who were subsequently diagnosed with any of 5 categories of dementia and evaluated time to dementia diagnosis in Cox Proportional Hazards models. We plotted cumulative hazard curves to illustrate the effect of race on dementia risk after controlling for age, sex, and occurrence of intervening stroke. RESULTS: Age at index stroke was significantly different between the 2 groups, with African-Americans being younger on average (70.0 [SD 12.5] in whites versus 64.5 [SD 14.1] in African-Americans, P < .0001). Adjusted hazard ratios revealed that African-American race increased risk for all 5 categories of dementia following incident stroke, ranging from 1.37 for AD to 1.95 for vascular dementia. Age, female sex, and intervening stroke likewise increased risk for dementia. CONCLUSIONS: African-Americans are at higher risk for dementia than whites within 5 years of ischemic stroke, regardless of dementia subtype. Incident strokes may have a greater likelihood of precipitating dementia in African-Americans due to higher prevalence of nonstroke cerebrovascular disease or other metabolic or vascular factors that contribute to cognitive impairment.


Subject(s)
Black or African American , Dementia/ethnology , Health Status Disparities , Stroke/ethnology , White People , Black or African American/psychology , Age Factors , Aged , Aged, 80 and over , Cognition Disorders/ethnology , Cognition Disorders/psychology , Databases, Factual , Dementia/diagnosis , Dementia/psychology , Female , Humans , Incidence , Male , Middle Aged , Prevalence , Prognosis , Proportional Hazards Models , Risk Assessment , Risk Factors , Sex Factors , South Carolina/epidemiology , Stroke/diagnosis , Stroke/psychology , Time Factors , White People/psychology
2.
Sarcoidosis Vasc Diffuse Lung Dis ; 29(2): 119-27, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23461074

ABSTRACT

BACKGROUND: Although numerous reports have described the clinical features of sarcoidosis in various ethnic and racial groups, many have been limited by small size, homogenous populations, and relatively short follow-up periods. We report the clinical characteristics of a large, race-sex-age diverse cohort of sarcoidosis clinic patients followed in a large university medical center for an extended period of time. METHODS: This study included clinical data for sarcoidosis patients followed over a 12-year period at a sarcoidosis clinic at the Medical University of South Carolina. RESULTS: 1774 sarcoidosis patients were identified. Black females were more common (44%) than other race/gender combinations (p = 0.01). The diagnosis of sarcoidosis occurred > 3 months after the onset of symptoms in 48% of the cohort and > 1 year after the onset of symptoms in 25%. Anti-sarcoidosis treatment was required in 61% of the patients. Pulmonary function improved over time and the median corticosteroid requirement lessened. Compared to whites, blacks had more advanced radiographic stages of sarcoidosis (p < 0.0001), more organ involvement (p < 0.0001), and more frequently required anti-sarcoidosis medication (p < 0.0001). Compared to women, men had more advanced radiographic stages of sarcoidosis (p < 0.0001). CONCLUSIONS: The analysis indicates that sarcoidosis tends to improve over time in terms of pulmonary function and medication requirements. The disease was found to be more severe in blacks than whites. Treatment was not necessarily required. These results provide a comprehensive model of the course and treatment of sarcoidosis in the clinical setting.


Subject(s)
Black or African American , Glucocorticoids/therapeutic use , Sarcoidosis, Pulmonary/ethnology , White People , Adult , Age Distribution , Biopsy , Diagnosis, Differential , Disease Progression , Female , Follow-Up Studies , Humans , Lung/diagnostic imaging , Lung/pathology , Male , Middle Aged , Prevalence , Radiography, Thoracic , Respiratory Function Tests , Retrospective Studies , Sarcoidosis, Pulmonary/diagnosis , Sarcoidosis, Pulmonary/drug therapy , Severity of Illness Index , Sex Distribution , South Carolina/epidemiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...